Related Experiment Videos
Brain histamine in rats with hepatic encephalopathy
W A Fogel1, W Andrzejewski, C Maslinski
1Department of Biogenic Amines, Polish Academy of Sciences, Lodz.
Journal of Neurochemistry
|January 1, 1991
Summary
Chronic liver failure in rats significantly elevates brain histamine levels, particularly in the hypothalamus. This increase is linked to enhanced histamine synthesis from increased L-histidine availability, not reduced degradation.
Area of Science:
- Neuroscience
- Biochemistry
- Physiology
Background:
- Chronic liver failure can impact brain function.
- Histamine plays a role in central nervous system regulation.
- Portocaval anastomosis (PCA) is a model for inducing chronic liver failure.
Purpose of the Study:
- To investigate the effect of chronic liver failure on brain histamine levels in rats.
- To explore the mechanisms behind changes in brain histamine concentration.
Main Methods:
- Induction of chronic liver failure using portocaval anastomosis (PCA) in Wistar rats.
- Measurement of histamine concentrations in the hypothalamus and other brain regions.
- Assay of histamine-degrading enzyme (histamine N-methyltransferase) activity.
- Measurement of histidine decarboxylase activity and L-histidine availability.
Main Results:
- PCA rats showed a 2.4- to 13-fold increase in hypothalamic histamine and a 1.5- to 2.5-fold increase in other brain regions compared to controls.
- Histamine levels remained elevated between 10 and 120 days post-surgery.
- No significant changes in histamine concentration were observed in other tissues.
- Enzyme activities for histamine degradation and synthesis remained unchanged under specific conditions, but increased L-histidine availability suggested enhanced synthesis.
Conclusions:
- Chronic liver failure significantly increases histamine levels in the rat brain, especially the hypothalamus.
- The elevated brain histamine is likely due to enhanced synthesis, driven by increased L-histidine availability.
- These findings suggest a link between liver dysfunction and central histaminergic system alterations.